Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Omisirge
Gamida Cell Inc.
Omisirge
(OMIDUBICEL-ONLV)Orphan drugstandardGamida Cell Inc.
12.1 Mechanism of Action OMISIRGE is a nicotinamide (NAM) modified allogeneic hematopoietic progenitor cell therapy derived from cord blood used as an...
Matthew Krebs, Dr
The Christie Hospital
Nathalie ALADJIDI, Dr
University Hospital, Bordeaux
Amel Karaa, MD, M.D
Massachusetts General Hospital
📍 BOSTON, MA
Petros Kountouris, PhD
Cyprus Institute of Neurology and Genetics (CING)
Gian Luca Forni
Ospedali Galliera - SSD Microcitemia, anemie congenite e dismetabolismo del ferro
Dittus Christopher, DO, MPH
UNC Lineberger Comprehensive Cancer Center